Matrix Evidence is going to be working with the BMJ Evidence Centre on a contract to deliver Technology Assessment Reviews (TARS) for the National Institute for Health Research. As one of the first agreements of this type reached with a research group outside of the university system, the contract is a real milestone.
TARS are commissioned to meet the urgent needs of national NHS decision-making bodies and policy customers, such as the National Institute for Health and Clinical Excellence (NICE). TARS are most commonly produced to inform NICE Appraisal Committee guidance on the use of new and existing medicines, treatments and procedures within the NHS in England and Wales. A defining characteristic of TARS is the need to produce the highest quality reviews of evidence to strict deadlines. The capacity of both the BMJ Evidence Centre and Matrix Evidence to deliver the required expertise in a timely fashion will be crucial.
Dr Tony Munton, Managing Director of Matrix Evidence, said ‘We are delighted to be providing economic and review expertise to our partnership with the BMJ Evidence Centre on what is an extremely important contract for the NHS”.
Dr Rubin Minhas, Clinical Director of BMJ Evidence Centre said: “This contract acknowledges the rigour of our methodology at the Evidence Centre as we are required to produce high quality assessment reports to strict timetables”.
